Y-mAbs Therapeutics Inc (NASDAQ:YMAB)

4.54
Delayed Data
As of Jan 26
 -0.18 / -3.81%
Today’s Change
2.94
Today|||52-Week Range
20.48
-6.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2017
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Operating ActivitiesNet Income / Starting Line-----14.1M-15.9M
 
 
 
Depreciation----14.0K19.0K
 
 
 
Total Other Cash Flow----491.0K915.0K
 
 
 
Funds From Operations-----13.6M-15.0M
 
 
 
Funds From/For Other Operating Expenses----22.0K-1.5M
 
 
 
Net Cash Flow - Operating Activities-----13.6M-13.5M
 
 
 
 
InvestingCapital Expenditures-----57.0K-126.0K
 
 
 
Net Cash Flow Investing-----57.0K-126.0K
 
 
 
 
FinancingShort Term Borrowings----0.000.00--
Long Term Borrowings----0.000.00--
Long Term Debt Reduction----0.000.00--
Net Proceeds Stock Sale-----1.8M0.00
 
 
Common Preferred Redeemed----0.000.00--
Common Dividends----------
Cash Dividends Paid - Total----0.000.00--
Other Sources - Financing----0.000.00--
Other Uses - Financing----0.000.00--
Net Cash Flow - Financing-----1.8M0.00
 
 
 
Exchange RateEffect of Exchange Rate on Cash----24.0K13.0K
 
 
 
 
Net Change In Cash0.000.00-15.5M-13.6M